Dana Graichen, MD
Ophthalmology · Sanford, MENPI 1831176312
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $779 of the $891 with a category attached, or 87.5%. 8 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 48.4% of the total. Reporting peaked in 2019 at $256 and has fallen 77.5% since, to $58 in 2025.
Across 39 payments — averaging $22.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$431
- Genentech USA, Inc.$109
- AbbVie$108
- Novartis$94
- Optovue, Inc.$74
- Sun Pharmaceutical Industries Inc.$38
- plus $37 from 2 others
What the payments were for
- Food & beverage$77987%
- Education$758%
- Gifts$374%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 20 | $431 |
| Genentech USA, Inc. | 5 | $109 |
| AbbVie | 6 | $108 |
| Novartis | 1 | $94 |
| Optovue, Inc. | 3 | $74 |
| Sun Pharmaceutical Industries Inc. | 2 | $38 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
How this compares
$891 in reported general payments places this provider in the 65th percentile of 74 ophthalmology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 18 | $532 |
| Ketorolac Tromethamine | 11 | $154 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Sanford
- Robert RiceSanford$388
- Kyle PackerSanford$161
- Charles ZacksPortland$36K
- Martin WhitakerNorway$5K
- Hallie HahnPortland$5K
- Curt YoungBangor$5K
- Samuel SolishPortland$4K
- Ravindra ShahPortland$4K
- Richard FrancePortland$4K
- Cynthia SelfBangor$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.